Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95095504 | 9509550 | 4 | F | 20160824 | 20130909 | 20160824 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-17248030 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 61.22000 | KG | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95095504 | 9509550 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 10 MG, QD | 0E61036B | 21436 | 10 | MG | QD | ||||||
| 95095504 | 9509550 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Unknown | 100 MG, BID | U | 0 | 100 | MG | BID | ||||||
| 95095504 | 9509550 | 3 | C | ATIVAN | LORAZEPAM | 1 | Unknown | UNK, PRN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95095504 | 9509550 | 1 | Bipolar disorder |
| 95095504 | 9509550 | 2 | Bipolar disorder |
| 95095504 | 9509550 | 3 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95095504 | 9509550 | Breast feeding | |
| 95095504 | 9509550 | Maternal exposure before pregnancy | |
| 95095504 | 9509550 | Normal newborn | |
| 95095504 | 9509550 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |